Nyrada Inc

ASX:NYR ISIN:AU0000070195

Nyrada IncNyrada is a preclinical stage, drug discovery, and development company, specialising in novel small molecule drugs to treat cardiovascular and neurological diseases. The Company has two main programs, each targeting market sectors of significant size and considerable unmet clinical need. These are a cholesterol-lowering drug and a drug to treat brain injury, specifically traumatic brain injury and stroke.

 
    

News

Nyrada Inc (ASX:NYR) 57% Reduction in Total Cholesterol from Nyrada's NYX-PCSK9i In Vivo Study

🕔12/21/2020 10:20:51 AM 4003

Nyrada Inc (ASX:NYR) is pleased to report encouraging efficacy results from its cholesterol-lowering drug program which is directed at developing an oral PCSK9 inhibitor treatment for hypercholesterolemia (high cholesterol).

Read Full Article
###

1,603 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 17) (Since Published: 1603) 

Company Data

    Headquarters
  • Level 4, 828 Pacific Highway
    Gordon NSW 2072
    Australia
  • Telephone
  • +61-2-9053-1990 
  • Fax
  • +61-2-9053-1999 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.nyrada.com
  • E:
  • info@nyrada.com

More News Results

  • 2024/03/28: Nyrada Commences Key Brain Injury Program Preclinical Study*
  • 2024/03/15: Notice of Change of Interests of Substantial Securityholder*
  • 2024/03/15: Notice of Change of Interests of Substantial Securityholder*
  • 2024/03/15: Cleansing Statement*
  • 2024/03/15: Application for quotation of securities - NYR*
  • 2024/03/15: Amended and Restated Certificate of Incorporation and Bylaw*
  • 2024/03/14: Change of Director's Interest Notice - CC*
  • 2024/03/14: Change of Director's Interest Notice - RW*
  • 2024/03/14: Change of Director's Interest Notice - MF*
  • 2024/03/14: Change of Director's Interest Notice - JM*
*refer to company website

Social Media